342O Intracranial administration of CTLA-4 and PD-1 immune checkpoint blocking monoclonal antibodies in recurrent glioblastoma (rGB): A multi-cohort adaptive phase I clinical trial.
Saved in:
| Title: | 342O Intracranial administration of CTLA-4 and PD-1 immune checkpoint blocking monoclonal antibodies in recurrent glioblastoma (rGB): A multi-cohort adaptive phase I clinical trial. |
|---|---|
| Authors: | Neyns, B.1 (AUTHOR), Schwarze, J.K.1 (AUTHOR), Bertels, C.1 (AUTHOR), Geens, W.2 (AUTHOR), Tijtgat, J.1 (AUTHOR), Awada, G.1 (AUTHOR), Vaeyens, F.3 (AUTHOR), Cras, L.4 (AUTHOR), Vanbinst, A-M.5 (AUTHOR), Everaert, H.6 (AUTHOR), Michotte, A.4 (AUTHOR), Bruneau, M.2 (AUTHOR), Forsyth, R.4 (AUTHOR), Tuyaerts, S.7 (AUTHOR), Duerinck, J.2 (AUTHOR) |
| Source: | Annals of Oncology. 2021 Supplement 5, Vol. 32, pS516-S517. 2p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2021.08.006 |
